Menu
GeneBe

USP8

ubiquitin specific peptidase 8, the group of Ubiquitin specific peptidases

Basic information

Region (hg38): 15:50424379-50514421

Links

ENSG00000138592NCBI:9101OMIM:603158HGNC:12631Uniprot:P40818AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive spastic paraplegia type 59 (Supportive), mode of inheritance: AR
  • developmental and epileptic encephalopathy (Limited), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the USP8 gene.

  • Hereditary spastic paraplegia (112 variants)
  • not provided (18 variants)
  • - (2 variants)
  • not specified (1 variants)
  • USP8-related condition (1 variants)
  • Pituitary dependent hypercortisolism (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP8 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
30
clinvar
6
clinvar
36
missense
50
clinvar
3
clinvar
12
clinvar
65
nonsense
1
clinvar
2
clinvar
3
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
1
5
non coding
11
clinvar
6
clinvar
17
Total 1 0 53 44 24

Variants in USP8

This is a list of pathogenic ClinVar variants found in the USP8 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-50439016-G-C Benign (Dec 16, 2020)1295795
15-50439097-T-C Likely benign (Apr 13, 2018)742571
15-50439109-C-T Hereditary spastic paraplegia Likely benign (Jun 24, 2023)789411
15-50439182-G-C Hereditary spastic paraplegia Uncertain significance (Nov 22, 2023)2910296
15-50439193-C-T Hereditary spastic paraplegia Benign (Jan 31, 2024)1600612
15-50439194-G-A Hereditary spastic paraplegia Likely benign (Aug 24, 2023)2797257
15-50439197-A-G Hereditary spastic paraplegia Likely benign (Jul 13, 2023)2831270
15-50441511-ATTG-A Hereditary spastic paraplegia Benign (Jun 24, 2023)1606296
15-50449385-T-C Hereditary spastic paraplegia Likely benign (Dec 14, 2023)1629850
15-50449392-A-C Benign (Jun 08, 2017)781991
15-50449404-A-C Hereditary spastic paraplegia Uncertain significance (Jul 09, 2019)944583
15-50449418-C-T Hereditary spastic paraplegia Uncertain significance (Jul 05, 2022)1944960
15-50449447-C-A Hereditary spastic paraplegia Likely benign (Dec 31, 2019)705055
15-50449447-C-T Hereditary spastic paraplegia Likely benign (Mar 29, 2023)2715851
15-50449467-C-G Hereditary spastic paraplegia Uncertain significance (Mar 10, 2021)1438686
15-50449489-C-G Hereditary spastic paraplegia Uncertain significance (May 23, 2022)1994556
15-50449492-A-G Hereditary spastic paraplegia Uncertain significance (Jul 18, 2019)569358
15-50459061-C-T Hereditary spastic paraplegia Uncertain significance (Aug 30, 2021)528042
15-50459064-C-T Hereditary spastic paraplegia Benign (Dec 07, 2023)704630
15-50459143-C-G Hereditary spastic paraplegia Uncertain significance (Nov 01, 2022)2061843
15-50459158-A-T Hereditary spastic paraplegia Uncertain significance (Oct 24, 2023)2784231
15-50462267-T-C Hereditary spastic paraplegia Likely benign (Jan 27, 2024)2059829
15-50462294-G-C Hereditary spastic paraplegia Uncertain significance (Dec 07, 2022)2725674
15-50462296-A-G Hereditary spastic paraplegia Uncertain significance (Jan 01, 2022)1934655
15-50462311-C-G Hereditary spastic paraplegia Uncertain significance (Nov 21, 2023)2722157

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
USP8protein_codingprotein_codingENST00000433963 1976704
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.004.57e-8125722091257310.0000358
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.874395640.7790.00002897316
Missense in Polyphen188299.060.628644036
Synonymous1.001761940.9080.000009512073
Loss of Function6.66255.60.03600.00000286736

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009600.0000958
Ashkenazi Jewish0.0001140.0000992
East Asian0.000.00
Finnish0.00004640.0000462
European (Non-Finnish)0.00003620.0000352
Middle Eastern0.000.00
South Asian0.000.00
Other0.0001670.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Hydrolase that can remove conjugated ubiquitin from proteins and therefore plays an important regulatory role at the level of protein turnover by preventing degradation. Converts both 'Lys-48' an 'Lys-63'-linked ubiquitin chains. Catalytic activity is enhanced in the M phase. Involved in cell proliferation. Required to enter into S phase in response to serum stimulation. May regulate T-cell anergy mediated by RNF128 via the formation of a complex containing RNF128 and OTUB1. Probably regulates the stability of STAM2 and RASGRF1. Regulates endosomal ubiquitin dynamics, cargo sorting, membrane traffic at early endosomes, and maintenance of ESCRT-0 stability. The level of protein ubiquitination on endosomes is essential for maintaining the morphology of the organelle. Deubiquitinates EPS15 and controles tyrosine kinase stability. Removes conjugated ubiquitin from EGFR thus regulating EGFR degradation and downstream MAPK signaling. Involved in acrosome biogenesis through interaction with the spermatid ESCRT-0 complex and microtubules. Deubiquitinates BIRC6/bruce and KIF23/MKLP1. {ECO:0000269|PubMed:16520378, ECO:0000269|PubMed:17711858, ECO:0000269|PubMed:18329369, ECO:0000269|PubMed:9628861}.;
Disease
DISEASE: Pituitary adenoma 4, ACTH-secreting (PITA4) [MIM:219090]: A form of pituitary adenoma, a neoplasm of the pituitary gland and one of the most common neuroendocrine tumors. Pituitary adenomas are clinically classified as functional and non-functional tumors, and manifest with a variety of features, including local invasion of surrounding structures and excessive hormone secretion. Functional pituitary adenomas are further classified by the type of hormone they secrete. PITA4 results in excessive production of adrenocorticotropic hormone. This leads to hypersecretion of cortisol by the adrenal glands and ACTH-dependent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:28505279}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Cushing,s syndrome - Homo sapiens (human);Endocytosis - Homo sapiens (human);Mitophagy - animal - Homo sapiens (human);EGF-EGFR Signaling Pathway;Signaling by WNT;Signal Transduction;Post-translational protein modification;Metabolism of proteins;Regulation of FZD by ubiquitination;Downregulation of ERBB2:ERBB3 signaling;Downregulation of ERBB2 signaling;Ub-specific processing proteases;Deubiquitination;Signaling by ERBB2;Negative regulation of MET activity;Signaling by MET;Signaling by Receptor Tyrosine Kinases;ErbB2/ErbB3 signaling events;Internalization of ErbB1;TCF dependent signaling in response to WNT (Consensus)

Recessive Scores

pRec
0.121

Intolerance Scores

loftool
0.379
rvis_EVS
0.4
rvis_percentile_EVS
76.45

Haploinsufficiency Scores

pHI
0.216
hipred
Y
hipred_score
0.831
ghis
0.546

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.603

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Usp8
Phenotype
growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; liver/biliary system phenotype; embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Zebrafish Information Network

Gene name
usp8
Affected structure
motor neuron
Phenotype tag
abnormal
Phenotype quality
branched

Gene ontology

Biological process
mitotic cytokinesis;ubiquitin-dependent protein catabolic process;endosome organization;Ras protein signal transduction;cell population proliferation;protein deubiquitination;regulation of protein stability;regulation of protein localization;protein K63-linked deubiquitination;protein K48-linked deubiquitination;cellular response to dexamethasone stimulus;positive regulation of canonical Wnt signaling pathway;regulation of protein catabolic process at postsynapse, modulating synaptic transmission;cellular response to nerve growth factor stimulus
Cellular component
nucleus;cytoplasm;early endosome;cytosol;postsynaptic density;extrinsic component of plasma membrane;midbody;extrinsic component of endosome membrane;dendritic spine;glutamatergic synapse
Molecular function
cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding;SH3 domain binding;cadherin binding